Target intelligence / Profile preview

Novel transcript, sense intronic to SPIDR (ENSG00000299387)

Target
ENSG00000299387
Molecular classification
Other (long non-coding RNA, lncRNA gene)
01

Overview

ENSG00000299387, described as novel transcript, sense intronic to SPIDR, is a predicted long non-coding RNA (lncRNA) gene located within the intronic region of the protein-coding gene SPIDR on the sense DNA strand. This annotation signifies that it does not encode a protein product, and there is currently no information about specific molecular function, involvement in signaling pathways, or therapeutic relevance. There are no reported aliases beyond the systematic description. No approved drugs, clinical candidates, or mechanisms of molecular targeting are associated with this transcript, and its biological function and disease links have yet to be determined in the scientific literature or major databases. No evidence exists to support use as a therapeutic target or as a biomarker, nor are there known safety concerns related to its modulation. Given current knowledge, this transcript is best considered as an uncharacterized lncRNA within the human genome, with a need for further research to determine its biological significance, if any.

Other names
ENSG00000299387sense intronic lncRNA within SPIDR
02

Biological functions

Unknown (no curated or experimentally validated biological function as of current annotation; presumed functional class is lncRNA, possibly involved in gene regulation)
03

Disease associations

None known (no established association with disease as of current databases)

Beyond the preview

Go deeper on Novel transcript, sense intronic to SPIDR (ENSG00000299387).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, sense intronic to SPIDR (ENSG00000299387).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call